Clinical Cancer Research Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paskett, E. D.
Right arrow Articles by Holland, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paskett, E. D.
Right arrow Articles by Holland, J.
Clinical Cancer Research Vol. 12, 3601s-3605s, June 1, 2006
© 2006 American Association for Cancer Research

CALGB 50th: Tomorrow's Cancer Treatments Today

Cancer and Leukemia Group B Cancer Control and Health Outcomes Committee: Origins and Accomplishments

Electra D. Paskett1, Deborah Schrag2, Alice Kornblith3, Elizabeth B. Lamont4, Jane C. Weeks3, James R. Marshall5, Charles Shapiro1 and Jimmie Holland2

Authors' Affiliations: 1 Comprehensive Cancer Center, Ohio State University, Columbus, Ohio; 2 Memorial Sloan-Kettering Cancer Center, New York, New York; 3 Dana-Farber Cancer Institute; 4 Institute for Technology Assessment, Massachusetts General Hospital Cancer Center, Boston, Massachusetts; and 5 Roswell Park Cancer Institute, Buffalo, New York

Requests for reprints: Electra D. Paskett, Comprehensive Cancer Center, Ohio State University, A356 Starling Loving Hall, 320 West 10th Avenue, Columbus, OH 43210. Phone: 614-293-3917; Fax: 614-293-5611.

Cancer and Leukemia Group B (CALGB) has conducted protocols in cancer prevention and control, psycho-oncology, and health services for many years. Significant findings from the studies have emerged and have helped shape the practice of medicine and the direction of future research in these areas. This article describes the origins of the Cancer Control and Health Outcomes Committee within CALGB and briefly describes significant findings and future work. The success CALGB has had with psycho-oncology and health services research has paved the way for other cooperative groups to develop these modalities. Cancer control research is growing and continues to gather momentum. This type of research is integral to providing quality care to patients and healthy populations.




This article has been cited by other articles:


Home page
 J Natl Cancer Inst MonogrHome page
E. P. Rock, J. A. Scott, D. L. Kennedy, R. Sridhara, R. Pazdur, and L. B. Burke
Challenges to Use of Health-Related Quality of Life for Food and Drug Administration Approval of Anticancer Products
J Natl Cancer Inst Monographs, October 1, 2007; 2007(37): 27 - 30.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2006 by the American Association for Cancer Research.